Lexaria Bioscience Corp. Discusses Potential of DehydraTECH™ CBD for Revolutionary Hypertension Solution with The Stock Day Podcast

May 07, 12:47 PM
The Stock Day Podcast welcomed Lexaria Bioscience Corp. (LEXX)(“the Company”), a company with a proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.